$34.54
0.872.58%
At close: Jun 18, 5:00 PM EST
$34.40
-0.14-0.41%
After Hours: 7:49 PM EST
Cogent Biosciences Inc Earnings Estimates
COGTNASDAQ
Cogent Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:COGT
Cogent Biosciences (COGT) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $-0.56 and quarterly revenue of N/A.
In the most recent quarter (Q1), Cogent Biosciences reported EPS of $-0.53, beating estimates of $-0.54 by 0.02%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Cogent Biosciences has averaged an EPS surprise of 0.08% and a revenue surprise of 0.00%.
Earnings Date
Aug 4
EPS Estimate
$-0.560
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Cogent Biosciences Earnings History
Analyze the earnings history of Cogent Biosciences using advanced sorting and filters.
Loading calendar...
Cogent Biosciences (COGT) Earnings Per Share
The chart below shows Cogent Biosciences's reported EPS compared to analyst estimates over recent quarters.
Cogent Biosciences (COGT) Revenue
The chart below shows Cogent Biosciences's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Cogent Biosciences (NASDAQ:COGT) reporting earnings?
Cogent Biosciences (COGT) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
What were the latest earnings per share (EPS) for Cogent Biosciences (NASDAQ:COGT)?
The Actual EPS was $-0.53, which beat the estimate of $-0.54.
What were Cogent Biosciences’s (NASDAQ:COGT) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
